Samsung Biologics acquires GSK's US drug production facility for $280 million, boosting capacity and responding to US market ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
THE CHOSUNILBO on MSN
Samsung Biologics, Celltrion announce major expansion into ADC production
South Korea’s two leading biopharmaceutical companies, Samsung Biologics and Celltrion, unveiled ambitious plans to enter the ...
Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs present new challenges.
Scientists have developed a new strategy to enhance pharmaceutical production in Chinese hamster ovary (CHO) cells, which are commonly used to manufacture protein-based drugs for treating cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback